Keyphrases
Polymorphic Ventricular Tachycardia
100%
COVID-19
79%
Quinidine
75%
Ventricular Fibrillation
53%
Myocarditis
52%
Coronary Artery Disease
50%
Echocardiographic
50%
Immune Checkpoint Inhibitors
50%
Arrhythmic Storm
45%
Left Ventricular Ejection Fraction
42%
Heart Failure
35%
Coupling Interval
30%
Ventricular Tachycardia
29%
Right Ventricular
28%
Clinical Outcomes
27%
Odds Ratio
25%
Consecutive Patients
25%
Long QT Syndrome
25%
Cardiac Arrest
25%
Severe Aortic Stenosis
25%
QT Interval
25%
Coronavirus Disease 2019 Vaccine
25%
Vaccine Response
25%
Single-center Retrospective Study
25%
Prognostic Impact
25%
Grapefruit Juice
25%
Palpation
25%
Healthy Volunteers
25%
Mitral Regurgitation
25%
Healthy Individuals
25%
Non-severe
25%
Sustained Monomorphic Ventricular Tachycardia
25%
Clinical Presentation
25%
Early Repolarization
25%
Vaccination
25%
Subcutaneous Implantable Cardioverter-defibrillator (S-ICD)
25%
Pooled Analysis
25%
Emergency Therapy
25%
Left Ventricular Function
25%
Torsades Des Pointes
25%
High-degree Atrioventricular Block
25%
Lung Ultrasound Score
25%
Mechanism Diagnosis
25%
Differential Diagnosis
25%
Lung Ultrasound
25%
Left Atrial Strain
25%
COVID-19 Patients
25%
Arrhythmogenic Right Ventricular Cardiomyopathy
25%
Multimodal Imaging
25%
Prognostic Value
25%
Medicine and Dentistry
Mitral Insufficiency
60%
Polymorphic Ventricular Tachycardia
50%
COVID-19
50%
Omicron Coronavirus Variant
50%
Congestive Heart Failure
38%
Ventricular Tachycardia
35%
Stroke Volume
30%
Implantable Automatic Defibrillator
29%
Infection
25%
Aortic Stenosis
25%
Heart Arrest
25%
Palpitations
25%
Subcutaneous Implantable Cardioverter Defibrillator
25%
Monomorphic Ventricular Tachycardia
25%
Retrospective Study
25%
Coronavirinae
25%
Myocarditis
25%
Pooled Analysis
25%
Torsade Des Pointes
25%
Ventricular Fibrillation
25%
Emergency Treatment
25%
Second-Degree Atrioventricular Block
25%
Differential Diagnosis
25%
Arrhythmogenic Right Ventricular Dysplasia
25%
Multimodality Imaging
25%
Messenger RNA
25%
Diseases
25%
Cardiac Dysrhythmia
22%
Supraventricular Tachycardia
20%
Cardiac Sarcoidosis
20%
Odds Ratio
16%
Atrioventricular Block
15%
Echocardiography
12%
Athletes
12%
Heart Left Ventricle Ejection Fraction
11%
Observational Study
10%
Symptomatology
8%
Meta-Analysis
8%
Critical Illness
8%
Extrasystole
8%
Immunosuppressive Treatment
8%
Heart Left Ventricle Compliance
7%
Aortic Valve
7%
Hospital Mortality
6%
Home Monitoring
6%
Shared Decision Making
6%
Forward Heart Failure
6%
Right Ventricular Function
5%
QT Prolongation
5%
Acute Heart Infarction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Polymorphic Ventricular Tachycardia
75%
Quinidine
75%
Heart Ventricle Fibrillation
56%
Myocarditis
53%
Coronavirinae
50%
Ischemic Heart Disease
50%
Infection
50%
Immune Checkpoint Inhibitor
50%
Diseases
50%
Cerebrovascular Accident
37%
Observational Study
29%
Normal Human
25%
Grapefruit
25%
Long QT Syndrome
25%
Torsade Des Pointes
25%
Mitral Valve Regurgitation
25%
Messenger RNA
25%
Coronary Artery Disease
20%
Hospital Mortality
15%
Amiodarone
14%
Heart Arrhythmia
14%
Congestive Heart Failure
13%
Antiarrhythmic Drug
11%
Heart Disease
9%
All Cause Mortality
9%
Heart Muscle Ischemia
8%
QT Prolongation
8%
Critical Illness
8%
Infarction
8%
Lidocaine
8%
Moxifloxacin
6%
Adverse Outcome
6%
Vascular Disease
6%
Left Ventricular Systolic Dysfunction
6%
Deterioration
6%
Progression Free Survival
6%
Cardiovascular Disease
6%
Retrospective Study
5%
Ischemia
5%
Virus Myocarditis
5%
Antiarrhythmic Agent
5%
